PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-50.78%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-4.70%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-40.44%
Operating expenses reduction while Healthcare median is 3.33%. Seth Klarman would investigate advantages.
-35.51%
Total costs reduction while Healthcare median is 2.53%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
0.99%
D&A change of 0.99% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
41.12%
EBITDA change of 41.12% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
40.44%
Income change of 40.44% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-17.42%
Other expenses reduction while Healthcare median is -3.13%. Seth Klarman would investigate advantages.
42.50%
Income change of 42.50% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
42.50%
Income change of 42.50% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
40.54%
EPS change of 40.54% versus flat Healthcare. Walter Schloss would verify quality.
40.54%
Diluted EPS change of 40.54% versus flat Healthcare. Walter Schloss would verify quality.
0.40%
Share count change of 0.40% versus stable Healthcare. Walter Schloss would verify approach.
0.40%
Diluted share change of 0.40% versus stable Healthcare. Walter Schloss would verify approach.